申请人:Pfizer Inc.
公开号:US20040014742A1
公开(公告)日:2004-01-22
The present invention provides compounds of formula (I)
1
wherein X, Y, R
1
, R
2
and R
3
are as defined hereinabove.
The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. Modulators of the CCR5 receptor may be useful in the treatment of various inflammatory diseases and conditions, and in the treatment of infection by HIV and genetically related retroviruses.
本发明提供了式(I)中的化合物,其中X、Y、R1、R2和R3如上文所定义。本发明的化合物是化学趋化因子CCR5受体的调节剂,特别是拮抗剂。CCR5受体的调节剂可能在治疗各种炎症性疾病和症状以及治疗HIV和遗传相关逆转录病毒感染方面有用。